touchMDT – Beyond tumor control: Long-term multidisciplinary management of TGCT
From touchPODCAST · 18:54
Show by touchpodcast
touchMDT for touchONCOLOGY Beyond tumor control: Long-term multidisciplinary management of TGCT Listen to our expert faculty explore the long-term multidisciplinary management of tenosynovial giant cell tumor (TGCT), including treatment decision-making, the CSF-1R inhibitor landscape, and regional care differences across the USA, Europe, and China. The multidisciplinary team Orthopedic oncologist—Dr. Wakenda Tyler, Columbia University Medical Center, New York, NY, USA Medical oncologist—Prof. Dr. Hans Gelderblom, Leiden University Medical Center, Leiden, Netherlands Orthopedic oncologist—Prof. Xiaohui Niu, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China This touchPODCAST is for HCPs outside of the UK and Ireland only. This activity is funded by an independent medical education grant from Merck KGaA. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchoncology.com
More episodes
- touchMDT – Recognizing TGCT earlier: Improving clinical recognition
- touchMDT – Beyond tumor control: Long-term management, recurrence and survivorship in TGCT
- Minimizing risk and maximizing care in metastatic breast cancer: A deep dive into ADC safety
- Presbyopia-correcting IOL decision-making: Answering the challenging clinical questions
- From first-line to next-gen: Tailoring hormonal contraception to the individual patient
- Glycogen storage disease type Ia: From pathophysiology to multidisciplinary management
- Building a shared AL vs. ATTR diagnostic pathway
- Integrating emerging AL therapies into real‑world MDT decisions
- Operationalizing the cardiac amyloidosis MDT
- touchEXPERT FOCUS - Integrating EGFR-directed strategies into early-stage NSCLC care
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.